On July 30 RedHill Biopharma announced topline safety and efficacy results from the first Phase III study of RHB104 a...Read More...The post Redhill&8217;s RHB104 are antibiotics the answer to Crohn&8217;s disease appeared first on Pharmaceutical T...
↧